Source:http://linkedlifedata.com/resource/pubmed/id/18271686
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2008-6-13
|
pubmed:abstractText |
The response of the pituitary- thyroid axis, reverse triiodothyronine (rT3), prolactin, and growth hormone (GH) levels following TRH stimulus (Relefact TRH 200 microg 2 amp. i.v.) was examined in patients with autoimmune diabetes type 1 (DM1, n=30), with autoimmune thyroiditis (AT, n=25), and with concurrent DM1 and AT (n=22) to evaluate the influence of DM1 and AT of autoimmune pathogenesis on the above-mentioned hormonal parameters. Statistical analysis (ANOVA) showed that: a) the response of TSH did not differ from control groups (C); b) free triiodothyronine (fT3), free thyroxine (fT4) and their ratio in DM1, DM1+AT and C rose in 120 and 180 min, while a similar increase was not seen in AT (p<0.000001); c) rT3 was not present in any group, with rT3 levels higher in AT (p<0.00002) and lower in DM1 (p<0.02); d) the response of GH had a paradoxical character in some patients in all groups, most often in DM1 (52 %, DM1 vs C, p <0.01). The characteristic response difference was not in the peak GH level, but the delayed return to basal levels in DM1 (p<0.0001) and an abrupt one in AT (p<0.0001). The major findings in DM1 were the differences in GH response, while significant impairment of pituitary-thyroid axis and PRL response to TRH was absent. AT was associated with impairment of TRH stimulated fT3, fT4, fT3/fT4 response and changes in rT3 levels, in spite of preserved TRH-stimulated TSH secretion. GH response in AT patients was also altered.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Hormones,
http://linkedlifedata.com/resource/pubmed/chemical/Human Growth Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Prolactin,
http://linkedlifedata.com/resource/pubmed/chemical/Thyrotropin-Releasing Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Thyroxine,
http://linkedlifedata.com/resource/pubmed/chemical/Triiodothyronine,
http://linkedlifedata.com/resource/pubmed/chemical/Triiodothyronine, Reverse
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0862-8408
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
57 Suppl 1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
S109-17
|
pubmed:meshHeading |
pubmed-meshheading:18271686-Adult,
pubmed-meshheading:18271686-Diabetes Mellitus, Type 1,
pubmed-meshheading:18271686-Female,
pubmed-meshheading:18271686-Hormones,
pubmed-meshheading:18271686-Human Growth Hormone,
pubmed-meshheading:18271686-Humans,
pubmed-meshheading:18271686-Male,
pubmed-meshheading:18271686-Middle Aged,
pubmed-meshheading:18271686-Pituitary Gland,
pubmed-meshheading:18271686-Prolactin,
pubmed-meshheading:18271686-Thyroid Gland,
pubmed-meshheading:18271686-Thyroiditis, Autoimmune,
pubmed-meshheading:18271686-Thyrotropin-Releasing Hormone,
pubmed-meshheading:18271686-Thyroxine,
pubmed-meshheading:18271686-Triiodothyronine,
pubmed-meshheading:18271686-Triiodothyronine, Reverse
|
pubmed:year |
2008
|
pubmed:articleTitle |
TRH test in patients with diabetes mellitus type 1 and/or autoimmune thyroiditis. Changes in the pituitary-thyroid axis, reverse T3, prolactin and growth hormone levels.
|
pubmed:affiliation |
Institute of Endocrinology, Prague, Czech Republic.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|